Webinar: Ask This Startup Founder About His Move to COVID-19 Tests

By Andy Gordon One small startup is stepping up in the fight against COVID-19.
You may have never heard of 20/20 GeneSystems. But members of our First Stage Investor research service have. We recommended they invest in 20/20 back in 2017.
And now 20/20 is doing something we could not have predicted in 2017. This dynamic startup is gearing up to provide COVID-19 tests.
The company’s main business (and why we recommended you invest in it in the first place) is layering artificial intelligence over the top of blood tests to help detect cancer in its earliest stages.
An increasing number of people have used its tests …read more



Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.